{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:35:46Z","timestamp":1774319746938,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clgc.2024.102076","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:21:21Z","timestamp":1710300081000},"page":"102076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["An Update on the Role of mpMRI and 68Ga-PSMA PET Imaging in Primary and Recurrent Prostate Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Hamed","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Rabi","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parham","family":"Geramifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Neshasteh-Riz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Sajadi Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Dadgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7559-5297","authenticated-orcid":false,"given":"Habib","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0003","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","article-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options","volume":"199","author":"Sanda","year":"2018","journal-title":"J Urol"},{"issue":"supplement 1","key":"10.1016\/j.clgc.2024.102076_bib0004","first-page":"P1576","article-title":"Machine learning based radiomics features of theranostics PET features in detection of Prostate cancer (PCa): a systematic review of 1703 patients","volume":"64","author":"Yazdanpanah","year":"2023","journal-title":"J Nucl Med"},{"issue":"supplement 2","key":"10.1016\/j.clgc.2024.102076_bib0005","first-page":"3282","article-title":"Prostate cancer and regional lymph node metastasis detection on deep learning synthesized attenuation corrected 68Ga-PSMA PET images","volume":"63","author":"Dorrigiv","year":"2022","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0006","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0007","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/cncr.23293","article-title":"A nomogram predicting long-term biochemical recurrence after radical prostatectomy","volume":"112","author":"Suardi","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar-Oromieh","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00259-015-3188-1","article-title":"68 Ga-PSMA-11 PET\/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients","volume":"43","author":"Sterzing","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0010","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s00259-015-3106-6","article-title":"PSMA PET\/CT with Glu-urea-Lys-(Ahx)-[68 Ga (HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer","volume":"42","author":"Giesel","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a 68 Ga-labelled PSMA ligand and 18 F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0012","series-title":"Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS\/MIC)","article-title":"Learning from multiple annotators: hierarchical deep learning training scheme for prostate Gleason cancer grading","author":"Arabi","year":"2021"},{"key":"10.1016\/j.clgc.2024.102076_bib0013","series-title":"Urologic Oncology: Seminars and Original Investigations","first-page":"334","article-title":"Clinical application of a 3D ultrasound-guided prostate biopsy system","volume":"29","author":"Natarajan","year":"2011"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0014","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","article-title":"68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging","volume":"23","author":"Eder","year":"2012","journal-title":"Bioconjugate Chem"},{"issue":"5","key":"10.1016\/j.clgc.2024.102076_bib0015","first-page":"797","article-title":"Impact of patient weight and emission scan duration on PET\/CT image quality and lesion detectability","volume":"45","author":"Halpern","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clgc.2024.102076_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","article-title":"OsiriX: an open-source software for navigating in multidimensional DICOM images","volume":"17","author":"Rosset","year":"2004","journal-title":"J Digit Imaging"},{"issue":"5","key":"10.1016\/j.clgc.2024.102076_bib0017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"Eiber","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0018","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2967\/jnumed.117.195255","article-title":"Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS version 1.0","volume":"59","author":"Rowe","year":"2018","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.eururo.2017.10.027","article-title":"PSMA-RADS version 1.0: a step towards standardizing the interpretation and reporting of PSMA-targeted PET imaging studies","volume":"73","author":"Rowe","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0021","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","article-title":"Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers","volume":"73","author":"Paner","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiol.09090475","article-title":"Prostate cancer: value of multiparametric MR imaging at 3 T for detection\u2014histopathologifc correlation","volume":"255","author":"Turkbey","year":"2010","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0023","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2018180788","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer","volume":"289","author":"Hicks","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropract Med"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000493169","volume":"102","author":"Kim","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2024.102076_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","article-title":"Improved specificity with 68 Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology","volume":"46","author":"Donato","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bju.14858","article-title":"Detection and localisation of primary prostate cancer using 68gallium prostate-specific membrane antigen positron emission tomography\/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology","volume":"126","author":"Kalapara","year":"2020","journal-title":"BJU Int"},{"issue":"7","key":"10.1016\/j.clgc.2024.102076_bib0029","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.118.221010","article-title":"Combination of 68Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis","volume":"60","author":"Chen","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clgc.2024.102076_bib0030","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of 68 Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0031","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11934-015-0505-y","article-title":"Lymph node staging in prostate cancer","volume":"16","author":"Sankineni","year":"2015","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.clgc.2024.102076_bib0033","first-page":"32","article-title":"A Phase 2 Study of 99m Tc-Trofolastat Chloride (MIP-1404) SPECT\/CT to Identify and Localize Prostate Cancer (PCa) in High-Risk Patients (pts) Undergoing Radical Prostatectomy (RP) and Extended Pelvic Lymph Node (ePLN) Dissection Compared to Histopathology","volume":"supplement 15","author":"Slawin","year":"2014"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0034","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00066-014-0765-3","article-title":"Radical prostatectomy versus external beam radiotherapy for localized prostate cancer","volume":"191","author":"Kim","year":"2015","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41181-021-00150-z","article-title":"On site production of [(18)F]PSMA-1007 using different [(18)F]fluoride activities: practical, technical and economical impact","volume":"6","author":"Maisto","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0036","first-page":"6","article-title":"More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET\/CT","volume":"22","author":"Pianou","year":"2019","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.clgc.2024.102076_bib0037","series-title":"68Ga-PSMA-11 PET: better at detecting prostate cancer than multiparametric MRI?","first-page":"738","author":"Civelek","year":"2018"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0038","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.juro.2016.02.3000","article-title":"Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer","volume":"196","author":"Rhee","year":"2016","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0039","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41391-018-0048-7","article-title":"68Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology","volume":"21","author":"Berger","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"11","key":"10.1016\/j.clgc.2024.102076_bib0040","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2967\/jnumed.116.189233","article-title":"Intraindividual comparison of 18F-PSMA-1007 PET\/CT, multiparametric MRI, and radical prostatectomy specimens in patients with primary prostate cancer: a retrospective, proof-of-concept study","volume":"58","author":"Kesch","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clgc.2024.102076_bib0041","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2019.07.005","article-title":"[68Ga-] PSMA-11 PET\/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard\u2013Implications for focal radiotherapy planning in primary prostate cancer","volume":"141","author":"Bettermann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clgc.2024.102076_bib0042","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00259-015-3257-5","article-title":"MRI versus 68 Ga-PSMA PET\/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer","volume":"43","author":"Zamboglou","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0044","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/2051415817720353","article-title":"EAU and NICE guidelines for the diagnosis and management of prostate cancer. How wide is the channel?","volume":"11","author":"Jones","year":"2018","journal-title":"J Clin Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0045","series-title":"NICE Guidelines on Prostate Cancer 2019","first-page":"1","author":"Dasgupta","year":"2019"},{"key":"10.1016\/j.clgc.2024.102076_bib0046","doi-asserted-by":"crossref","first-page":"k5290","DOI":"10.1136\/bmj.k5290","article-title":"NICE recommends MRI for suspected prostate cancer to reduce biopsies","volume":"363","author":"Wise","year":"2018","journal-title":"Br Med J Publ Group"},{"issue":"12","key":"10.1016\/j.clgc.2024.102076_bib0047","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","article-title":"Treatment outcomes from 68Ga-PSMA PET\/CT\u2014informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET","volume":"58","author":"Emmett","year":"2017","journal-title":"J Nucl Med"},{"issue":"24","key":"10.1016\/j.clgc.2024.102076_bib0048","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-18-0768","article-title":"PSMA ligand PET\/MRI for primary prostate cancer: staging performance and clinical ImpactPSMA-PET\/MRI in primary prostate cancer","volume":"24","author":"Grubm\u00fcller","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.clgc.2024.102076_bib0049","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clgc.2024.102076_bib0050","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00259-016-3346-0","article-title":"Intra-individual comparison of 68 Ga-PSMA-11-PET\/CT and multi-parametric MR for imaging of primary prostate cancer","volume":"43","author":"Giesel","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41824-022-00135-4","article-title":"(68)Ga-PSMA-11 PET\/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement","volume":"6","author":"Ferraro","year":"2022","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0052","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00259-019-04438-w","article-title":"Comparison of PSMA-ligand PET\/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis","volume":"46","author":"Afshar-Oromieh","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0053","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic accuracy of 68Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis","volume":"216","author":"Satapathy","year":"2021","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.clgc.2024.102076_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6434-2","article-title":"Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate cancer: a systematic review and meta-analysis","volume":"19","author":"Zhen","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13139-021-00701-x","article-title":"Mismatched imaging findings of prostate cancer diagnosis: 68 Ga-PSMA PET\/CT vs mpMRI","volume":"55","author":"Lopci","year":"2021","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0056","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0057","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.clgc.2024.102076_bib0058","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2967\/jnumed.119.235333","article-title":"68Ga-PSMA PET\/CT combined with PET\/ultrasound-guided prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsy results","volume":"61","author":"Liu","year":"2020","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0059","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1038\/s41598-020-67385-9","article-title":"Comparison of 68Ga-PSMA-617 PET\/CT with MpMRI for the detection of PCa in patients with a PSA level of 4\u201320 Ng\/Ml before the initial biopsy","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0060","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euf.2020.03.004","article-title":"Prospective evaluation of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography in primary prostate cancer diagnosis","volume":"7","author":"Lopci","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0061","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","article-title":"68Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study","volume":"200","author":"Lopci","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0062","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00259-019-04620-0","article-title":"68 Ga-PSMA PET\/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: is 68 Ga-PSMA PET\/CT guided biopsy the future?","volume":"47","author":"Donato","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0063","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.euros.2021.03.004","article-title":"Accuracy of prostate magnetic resonance imaging: reader experience matters","volume":"27","author":"Kang","year":"2021","journal-title":"Eur Urol Open Sci"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0064","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.2015142818","article-title":"Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging","volume":"277","author":"Muller","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.eururo.2020.09.015","article-title":"Measuring the quality of diagnostic prostate magnetic resonance imaging: a urologist\u2019s perspective","volume":"79","author":"Giannarini","year":"2020","journal-title":"Eur Urol"},{"issue":"1131","key":"10.1016\/j.clgc.2024.102076_bib0066","doi-asserted-by":"crossref","first-page":"20210415","DOI":"10.1259\/bjr.20210415","article-title":"Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score","volume":"95","author":"Giganti","year":"2022","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0067","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","article-title":"Prostate magnetic resonance imaging interpretation varies substantially across radiologists","volume":"5","author":"Sonn","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.clgc.2024.102076_bib0068","doi-asserted-by":"crossref","first-page":"110044","DOI":"10.1016\/j.ejrad.2021.110044","article-title":"Primary staging in patients with intermediate- and high-risk prostate cancer: multiparametric MRI and (68)Ga-PSMA-PET\/MRI\u2014what is the value of quantitative data from multiparametric MRI alone or in conjunction with clinical information?","volume":"146","author":"Skawran","year":"2022","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0069","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13550-022-00881-3","article-title":"Comparison of (68)Ga-PSMA PET\/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"EJNMMI Res"},{"issue":"8","key":"10.1016\/j.clgc.2024.102076_bib0070","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14287","article-title":"Diagnostic accuracy of (68) Ga-PSMA PET\/MRI and multiparametric MRI in detecting index tumours in radical prostatectomy specimen","volume":"75","author":"Co\u015far","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0071","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2967\/jnumed.119.232504","article-title":"Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement","volume":"61","author":"Toriihara","year":"2020","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.clgc.2024.102076_bib0072","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00259-021-05261-y","article-title":"Diagnostic performance of 68 Ga-PSMA-11 PET\/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0073","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40644-022-00489-9","article-title":"Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer","volume":"22","author":"Glemser","year":"2022","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.clgc.2024.102076_bib0074","doi-asserted-by":"crossref","first-page":"600690","DOI":"10.3389\/fonc.2020.600690","article-title":"Comparison of manual and semi-automatic [(18)F]PSMA-1007 PET based contouring techniques for intraprostatic tumor delineation in patients with primary prostate cancer and validation with histopathology as standard of reference","volume":"10","author":"Spohn","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0075","doi-asserted-by":"crossref","first-page":"101242","DOI":"10.1016\/j.tranon.2021.101242","article-title":"68Ga-PSMA-HBED-CC PET\/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: a prospective single-institutional study","volume":"15","author":"Martinez","year":"2022","journal-title":"Transl Oncol"},{"issue":"9\u201310","key":"10.1016\/j.clgc.2024.102076_bib0076","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1159\/000509974","article-title":"Comparison of 68Ga-PSMA-I\/T PET-CT and multiparametric MRI for locoregional staging of prostate cancer patients: a pilot study","volume":"104","author":"\u00c7elen","year":"2020","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0077","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/diagnostics11030552","article-title":"Diagnostic role of 18F-PSMA-1007 PET\/CT in prostate cancer staging: a systematic review","volume":"11","author":"Awenat","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.clgc.2024.102076_bib0078","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68 Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0079","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4103\/ijnm.ijnm_62_21","article-title":"SUVmax\/ADC ratio as a molecular imaging biomarker for diagnosis of biopsy-na\u00efve primary prostate cancer","volume":"36","author":"Chinnappan","year":"2021","journal-title":"Ind J Nucl Med IJNM Off J Soc Nucl Med India"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MOU.0000000000000549","article-title":"Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer","volume":"28","author":"Meyer","year":"2018","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0081","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","article-title":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis","volume":"15","author":"Mannweiler","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.clgc.2024.102076_bib0082","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1007\/s00259-021-05501-1","article-title":"What\u2019s behind 68 Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns","volume":"48","author":"R\u00fcschoff","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.clgc.2024.102076_bib0083","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.21037\/tau-22-832","article-title":"Prediction of clinically significant prostate cancer using a novel 68Ga-PSMA PET-CT and multiparametric MRI-based model","volume":"12","author":"Cheng","year":"2023","journal-title":"Translat Androl Urol"},{"key":"10.1016\/j.clgc.2024.102076_bib0084","first-page":"1","article-title":"PSMA-PET in addition to mpMRI and biopsies to select prostate cancer patients for focal therapy","volume":"363","author":"Geboers","year":"2023","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bju.16037","article-title":"Can 68Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?","volume":"132","author":"Khanna","year":"2023","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.clgc.2024.102076_bib0086","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000528720","article-title":"Diagnostic performance and clinical impact of PSMA PET\/CT versus mpMRI in patients with a high suspicion of prostate cancer and previously negative biopsy: a prospective trial (PROSPET-BX)","volume":"107","author":"Lopci","year":"2023","journal-title":"Urol Int"},{"issue":"10","key":"10.1016\/j.clgc.2024.102076_bib0087","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2967\/jnumed.119.228320","article-title":"Multimodality imaging of prostate cancer","volume":"60","author":"Ghafoor","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0088","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2020.09.043","article-title":"False positive multiparametric magnetic resonance imaging phenotypes in the biopsy-na\u00efve prostate: are they distinct from significant cancer-associated lesions? Lessons from PROMIS","volume":"79","author":"Stavrinides","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0089","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiol.2015142856","article-title":"Computer-extracted features can distinguish noncancerous confounding disease from prostatic adenocarcinoma at multiparametric MR imaging","volume":"278","author":"Litjens","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1148\/radiol.2017162321","article-title":"Prostate cancer: diffusion-weighted MR imaging for detection and assessment of aggressiveness-comparison between conventional and Kurtosis models","volume":"284","author":"Tamada","year":"2017","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0091","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1038\/s41598-020-67385-9","article-title":"Comparison of 68Ga-PSMA-617 PET\/CT with mpMRI for the detection of PCa in patients with a PSA level of 4-20 ng\/ml before the initial biopsy","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0092","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"issue":"2","key":"10.1016\/j.clgc.2024.102076_bib0093","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/JU.0000000000001765","article-title":"Grading of multifocal prostate cancer cases in which the largest volume and the highest grade do not coincide within one lesion","volume":"206","author":"Matsumoto","year":"2021","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.clgc.2024.102076_bib0094","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0096","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2017.04.021","article-title":"Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using (68)Ga-HBED-CC PSMA-PET\/CT: a planning study based on histopathology reference","volume":"123","author":"Zamboglou","year":"2017","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2024.102076_bib0097","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.118.221010","article-title":"Combination of (68)Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis","volume":"60","author":"Chen","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0098","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","article-title":"Improved specificity with (68)Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology","volume":"46","author":"Donato","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.clgc.2024.102076_bib0099","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00259-019-04620-0","article-title":"(68)Ga-PSMA PET\/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: is (68)Ga-PSMA PET\/CT guided biopsy the future?","volume":"47","author":"Donato","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.clgc.2024.102076_bib0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0090-4295(00)00753-6","article-title":"Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy","volume":"56","author":"Chan","year":"2000","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.clgc.2024.102076_bib0101","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1464-410X.2008.08281.x","article-title":"Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men","volume":"103","author":"van den Bergh","year":"2009","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.clgc.2024.102076_bib0102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.eururo.2020.09.015","article-title":"Measuring the quality of diagnostic prostate magnetic resonance imaging: a urologist\u2019s perspective","volume":"79","author":"Giannarini","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0103","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","article-title":"(68)Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0","volume":"44","author":"Fendler","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2024.102076_bib0104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-022-00881-3","article-title":"Comparison of 68Ga-PSMA PET\/CT and multiparametric MRI for the detection of low-and intermediate-risk prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"EJNMMI Res"},{"issue":"3","key":"10.1016\/j.clgc.2024.102076_bib0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"[(68)Ga]Ga-PSMA versus [(18)F]PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102076_bib0106","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/cancers14061479","article-title":"Comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 PET\/CT in restaging of prostate cancer patients with PSA relapse","volume":"14","author":"Hoffmann","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:58:12Z","timestamp":1731563892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1558767324000478"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102076","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Update on the Role of mpMRI and 68Ga-PSMA PET Imaging in Primary and Recurrent Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102076"}}